Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 3Phase 3 2Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 395Neoplasms 338Prostatic Neoplasms 189Lung Neoplasms 176Colorectal Neoplasms 143Motor Activity 88Uterine Cervical Neoplasms 75Pancreatic Neoplasms 74Head and Neck Neoplasms 70Brain Neoplasms 69Carcinoma, Non-Small-Cell Lung 64Ovarian Neoplasms 60Carcinoma, Hepatocellular 51Rectal Neoplasms 49Colonic Neoplasms 46Glioblastoma 42Anxiety Disorders 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Neoplasm Metastasis 40Depression 39Hematologic Neoplasms 38Glioma 36Melanoma 35Stomach Neoplasms 33Multiple Myeloma 33Disease 33Sarcoma 31Carcinoma, Renal Cell 31Urinary Bladder Neoplasms 30Pain 28

Interventions

disitamab vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Advanced Breast Cancer × 90 days × Clear all
NCT05831878 2026-05-13

RC48-ADC in HER2-low Advanced Breast Cancer

RenJi Hospital

Phase NA Recruiting
36 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡